🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a study estimating the clinical difference between 300 mg and 150 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-03-13
Trial ID
NCT03350815
The goal of this Phase 3 clinical trial is to compare efficacy and safety o...
Status
Active Not Recruiting
Location
Rheumatology Clinic NZOZ Lecznica MAK-MED s.c.
Start Date
2025-05-26
Trial ID
NCT06630559
Treatments Being Tested
The purpose of this study was to demonstrate efficacy including effect on i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-08-31
Trial ID
NCT02404350
Treatments Being Tested
This study investigates the efficacy of secukinumab in necrobiosis lipoidic...
Status
Terminated
Location
Beth Israel Deaconess Medical Center
Start Date
2019-04-03
Trial ID
NCT03791060
Treatments Being Tested
This is a study to determine whether secukinumab is a potential therapy for...
Status
Completed
Location
Stanford Dermatology
Start Date
2017-06-21
Trial ID
NCT03079531
Treatments Being Tested
The purpose of the present study was to assess the efficacy of secukinumab ...
Status
Terminated
Location
Millennium Clinical Trials
Start Date
2023-08-10
Trial ID
NCT05722522
Treatments Being Tested
This single-center, prospective, observational study aimed to evaluate the ...
Status
Recruiting
Location
No. 1 Shuai Fu Yuan, Dongcheng District, Beijing
Start Date
2025-06-01
Trial ID
NCT07109765
Treatments Being Tested
Biologics such as secukinumab are currently the most effective treatment op...
Status
Completed
Location
AZ Maria Middelares
Start Date
2018-03-22
Trial ID
NCT04080661
Treatments Being Tested
This was an extension study of secukinumab prefilled syringes in subjects w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06-19
Trial ID
NCT01544595
Treatments Being Tested
This study is designed to support the optimal use of secukinumab by providi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-02-08
Trial ID
NCT02474069
Treatments Being Tested